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Introduction
Plants have demonstrated the ability to produce functionally active proteins from mammals or other eukaryotic organisms with therapeutic activity, such as human serum and growth regulatory proteins, antibodies, antigens, hormones and cytokines [1, 2] .
Despite providing many beneficial properties for protein production such as scalability, low production costs and in the case of vaccine production absence of pathogenic contaminants, one of the major challenges for the use of plants as an alternative expression system is the relatively low expression yields of recombinant proteins [3] .
The stability of plant-derived recombinant proteins is considered the predominant factor that limits protein yields achieved by molecular farming [4] . In the past few years, chloroplast transformation technology has emerged as an alternative platform that offers many advantages over nuclear transformation such as high levels of transgene expression due to high copy number, transgene containment via maternal inheritance of plastids and multi-gene expression in a single transformation event [5, 6] . However, previous studies have also shown that, for certain eukaryotic proteins, chloroplast transformation has only provided a limited expression yield [7] [8] [9] [10] [11] . In this sense, new strategies should be explored in order to improve the production yield of foreign proteins expressed in plants and increase the commercial potential of plant-based production systems.
SAG1 is the main surface antigen of the intracellular parasite Toxoplasma gondii, the causal agent of toxoplasmosis [12, 13] . In human, toxoplasmosis is usually asymptomatic in healthy individuals. However, in pregnant women, congenital infection can cause severe neonatal malformations [14] . Although a vaccine against human infection with T. gondii is not yet available, an effective vaccine against toxoplasmosis may be valuable to prevent both fetal infection and reactivation. In this context, numerous studies have established the potential of SAG1 as a candidate to produce an anti-T. gondii vaccine [15] [16] [17] [18] [19] [20] [21] . Previous attempts to express SAG1 using various classical heterologous expression systems have been challenged by low expression levels or poor antigenicity of the recombinant SAG1 protein [22] [23] [24] [25] [26] [27] . SAG1 is thus both a promising antigen for vaccine development, and a good candidate to optimize an antigen production strategy using an alternative protein expression system such as plant-based protein production [26, 27] .
The heat shock proteins belonging to the 90-kDa family (HSP90) are highly conserved among bacteria, yeast, plants, and animals [28] . HSP90s function as molecular chaperones to prevent inappropriate associations or aggregations of partially folded proteins [29] . In addition, HSP90s promote cell survival in response to many forms of cellular stress [30] . In general, HSP90s are ubiquitously expressed at high levels, with HSP90s making between 1 and 2% of total soluble proteins [31] . We hypothesize the high level of constitutive HSP90 expression combined with its chaperone properties may be utilized to enhance the expression of recombinant proteins in plants by using HSP90 as a carrier protein and by expressing recombinant proteins of interest as HSP90 fusion proteins.
Previously Echeverria et al. [32] demonstrated that the 90-kDa heat shock protein of Leishmania infantum (LiHsp83) is a good candidate to carry Toxoplasma antigens produced as recombinant proteins in bacteria. Therefore, within this study we use LiHsp83 as a carrier for T. gondii SAG1 antigen in order to improve its expression in transplastomic plants. Our findings show that fusion of SAG1 to LiHsp83 significantly increases the level of SAG1 accumulation in tobacco chloroplasts.
Material and Methods

Vector construction
The vectors pAF-SAG1and pAF-LiHsp83:SAG1 were constructed as previously described [11, 34, 35] with slight modifications. The SAG1 sequence was amplified by polymerase chain reaction (PCR) from the pRSET-SAG177-322 vector [33] using the primers 5'-cccgggCACTTCACTCTCAAGTGCCC-3' (upstream, lowercase indicates SmaI restriction site) and 5'-ctcgagAGCAAAGATGGAAACATGAG-3' (downstream, lowercase indicates XhoI restriction site). The SAG1 fragment was cloned into the vector pAF-TDHIS to generate the plasmid pAF-SAG1 as was previously described by [11] . The LiHsp83 sequence was amplified by PCR from the pQ-LiHsp83 vector [36] using the primers 5'-cccgggACGGAGACGTTCGCGTTCCAG-3' (upstream, lowercase indicates SmaI restriction site) and 5'-gttaacGTCCACCTGCTCCATGCTGG-3' (downstream, lowercase indicates HpaI restriction site). The LiHsp83 fragment was digested with SmaI and HpaI restriction enzymes and cloned into the pAF-SAG1 plasmid digested by SmaI, to give plasmid pAF-LiHsp83:SAG1.
Transformation and regeneration of transformed chloroplast plants
In vitro-grown tobacco (Nicotiana tabacum cv. Petite Havana) leaves were transformed by bombarding pAF-SAG1 or pAF-LiHsp83:SAG1 plasmids-coated gold particles using the PDS1000/He (Bio Rad, Hercules, CA) biolistic device, as previously described [11, 37] . Leaves were then cut into small pieces and placed on regeneration RMOP medium containing 500 mg/L spectinomycin [11, 37] . After 2 cycles of shoot regeneration, the regenerated plants were moved to a greenhouse for homoplasmy confirmation and seed production.
Southern blot analysis
Ten µg of plant DNA was digested with BglII, separated on a 0.8% (w/v) agarose gel and transferred on to a nylon membrane. The digestion by BglII and BamHI of the chloroplast vector generated a 0.8-kb probe (P1) homologous to the flanking sequences ( Figure 1A ). Probe labelling, hybridization and detection were performed as previously described [11] . Homoplastic plants were grown in a greenhouse for further analysis.
Protein Extraction
Leaves from transplastomic plants and wild-type tobacco plants were ground in liquid nitrogen. For total protein extraction, 100 mg of grounded leaves were homogenized in 300 µl Laemmli buffer (0.5 M Tris-HCl pH 6.5, 4% SDS, 20% glycerol, 10% β-mercaptoethanol and 0.1% bromophenol blue). The total protein content was measured using the RC-DC protein assay (Bio Rad) with BSA as a standard according to the manufacturer's instructions.
To separate soluble and insoluble protein fractions, powdered leaves (100 mg) were homogenized in 500 μL of protein extraction buffer (20 mM NaPO4, 250 mM NaCl, 0.1% Triton X-100) [11, 38] and sonicated for 15 s. After centrifugation at 13,000 rpm, Laemmli buffer was added to soluble fraction (supernatant) and insoluble fraction (pellet).
SDS-PAGE and Western blot analysis
Leaf protein extracts were heated at 100°C for 5 min and separated by 10% (chLiHsp83-SAG1) or 15% (chSAG1) SDS-polyacrylamide gels which were either stained with coomassie brilliant blue or transferred onto PVDF membrane (GE Healthcare) using an Electro-transfer unit (Bio Rad). The membranes were ncubated with rabbit anti-SAG1 polyclonal antibody (1:500) or rabbit anti-LiHsp83 polyclonal antibody (1:500) followed by anti-rabbit IgG alkaline phosphatase conjugate as secondary antibody (1:5000; Sigma).
Phosphatase activity was detected using NBT/BCIP substrate (Promega, Fitchburg, WI).
The accumulation of recombinant proteins (chSAG1 and chLiHsp83-SAG1) in tobacco leaves was estimated by comparing plant extract samples with a serial dilution of known concentration of E. coli-purified SAG1 (EcSAG1) [33] , or E. coli-purified LiHsp83 (EcLiHsp83) [39] electrophoresed on the same polyacrylamide gel. The band intensity of purified EcSAG1 and EcLiHsp83 detected by Western blot was estimated with the "GelPro analyzer" software (Media Cybernetics, Rockville, MD) and used as a standard to build a calibration curve as previously described [11, 27] . The leaf-expressed chSAG1 band intensity detected by Western blot was estimated using the "Gel Pro analyzer" software and compared with a calibration curve obtained by the band intensity of EcSAG1, while the leaf-expressed chLiHsp83-SAG1 band intensity was compared with two calibration curves obtained from the band intensity of EcSAG1 or from the band intensity of EcLiHsp83.
Exclusively the intact band detected by Western blot was taken into account to estimate the chSAG1 and chLiHsp83-SAG accumulation. This analysis allowed us to have an estimation of the concentration of chSAG1 and chLiHsp83-SAG1 expressed in chloroplast transformed plants.
Reactivity of human serum samples
Human serum samples were obtained during routine serologic screening of pregnant women at Parasitology Department, ANLIS "Dr. Carlos G. Malbrán", Argentina, and analyzed by IgG-Indirect immunofluorescence assay (IFA) and in-house IgM-ISAGA test. Lyophilized plant leaf stocks were used for oral administration to 8-to 10-wk-old mice as previously performed [11] . The leaf extracts was homogenized in PBS 1X buffer.
Oral immunization of mice
The chLiHsp83-SAG1 group received five doses of transplastomic leaf extracts (4-6 µg of chLiHsp83-SAG1), at one-week intervals, while the control group received five doses of wild-type leaf extracts. A PBS group was also included. This group was orally immunized with five doses of PBS buffer.
Measurement of antibody responses
Antigen-specific antibodies were analyzed by enzyme linked immunosorbent assay (ELISA) as previously described [11, 26, 27] . Two weeks after the last immunization, blood was collected from the tail vein and sera were stored at -20°C until the antibody response analysis. Briefly, microtiter plates (Immuno Plate Maxiorp; Nunc, Roskilde, Denmark) were coated with rSAG1 (5 µg/ml, EcSAG1). Rat anti-mouse immunoglobulin G (IgG)-horseradish peroxidase conjugate (1:3000) was used as a secondary antibody (Sigma). Immune complexes were revealed with TMB (Invitrogen, Waltham, MA) and optical density was read at 650 nm with an automatic ELISA reader (Synergy H1, Bio-Tek, Winooski, VT). Serum samples were used at a 1:100 dilution. Pre-immune serum samples were used as negative controls.
Challenge infection
Two weeks after the last immunization, mice (eight per experimental group) were orally infected with 20 Me49 tissue cysts (sublethal dose) as previously achieved [11, 27] .
One month after the challenge, animals were sacrificed and their brains removed for tissue cyst quantification. The mean number of cysts per brain was determined under an optical microscope, by counting four samples of each homogenized brain.
Statistical analysis
Statistical analysis was carried out with the Prism 5.0 Software (GraphPad, La Jolla, CA) using one-way analysis of variance (ANOVA). A Bonferroni's test was used to compare means. P < 0.05 was considered significant.
Results
Cloning of SAG1 and LiHsp83-SAG1 fusion constructs
The SAG1 and LiHsp83-SAG1 sequences were fused to the promoter and 5′-untranslated region of the psbA gene (PpsbA) with a downstream box composed by the first 15 codons of the green fluorescence protein (GFP15) [34, 40] and to the tetramerization domain (TD) from the human transcription factor p53, inclusion of which has previously been demonstrated to favor the accumulation of antigenic peptides in tobacco chloroplasts [34] . Finally, a 6xHis-tag was included at the C-terminal region of the recombinant proteins ( Figure 1A ). The expression cassettes were inserted between the trnI and trnA genes into the chloroplast genome ( Figure 1A ).
Confirmation of transgene integration in transplastomic plants
The pAF-SAG1 and pAF-LiHsp83:SAG1 constructs were introduced into Nicotiana tabacum cv. Petite Havana chloroplasts by biolistic transformation [37] . 
Morphology of transplastomic plants
After rooting on Murashige and Skoog medium, transgenic plants were transferred to the greenhouse for seed production and morphological studies. SAG1 transplastomic lines exhibited normal growth and morphology. In contrast, LiHsp83-SAG1 transplastomic lines showed stunted growth during both in vitro and greenhouse conditions. Moreover, leaves from all transplastomic LiHsp83-SAG1 plant lines were chlorotic and pale in color as compared to wild-type tobacco plants, and this phenotype persisted in the successive generations ( Figure 2 ). Despite the stunted growth and chlorotic leaf phenotype of the LiHsp83-SAG1 transplastomic plants, they reached maturity, produced fertile seeds and yielded the same amount of seeds that are usually produced in wild-type plants.
Expression and quantification of the SAG1 protein
The expression of SAG1 in transformed plastome (chSAG1) was detected by
Western blot using an anti-SAG1 polyclonal antibody. A faint 34-kDa band was observed in total protein extracts obtained from mature leaves of transplastomic plants grown for 90 days after transplantation ( Figure 3A ). In addition to the 34-kDa band, other nonspecific signals were present in both SAG1 transplastomic plants and wild-type tobacco plants. As expected, the chSAG1 migrated at a slower rate on the gel compared to the E. coli-derived SAG1 (EcSAG1) due to the N-and C-terminal fusions mentioned above ( Figure 3 ).
To determine the levels of chSAG1 expression, plant tissue was lyophilized with the final weight reduced to 10-fold relative to the initial fresh weight (10X). The chSAG1 expression levels were then estimated by Western blot with an anti-SAG1 polyclonal antibody using a dilution series of EcSAG1 as reference ( Figure 3B ). 
Expression and quantification of LiHsp83-SAG1 fusion protein
We also investigated whether utilization of LiHsp83 as a carrier of SAG1 can improve the protein expression in transplastomic plants. When were only detected by anti-LiHsp83 antibody suggesting that these bands are N-terminal degradation products due to these bands were not detected by anti-SAG1 antibody ( Figure   4A ).
In order to evaluate the solubility of the fusion protein, total soluble and insoluble proteins were extracted from developed mature leaves. The specific 130-kDa band was observed mainly in the soluble fraction in 50 and 100-day-old plants by coomassie blue staining ( Figure 4B ).
Effect of leaf age on LiHsp83-SAG1 expression
To determine whether the leaf age affects the expression level of the recombinant fusion protein, transplastomic plants were grown in the greenhouse for 100 days and analyzed. The total protein content is normally higher in young and mature leaves than in old leaves because of higher proteolytic activity in senescent leaves [41] . Usually, the profiles of recombinant proteins matched those of the total protein content [41] . Contrary to expectation, the expression level of chLiHsp83-SAG1 in young leaves was barely detectable by coomassie blue staining ( Figure 5A ). However, we observed that the fusion protein mainly accumulated in mature and old leaves ( Figure 5A ).
ChLiHsp83-SAG1 accumulation in mature and old leaves was estimated by
Western blot analysis using EcSAG1 and EcLiHsp83 for reference as described in Material and Methods ( Figure 5B ). The relative amount of chLiHsp83-SAG1 fusion protein accumulated in transplastomic plants was up to approximately 100 µg per gram of FW (~2.5% of total cellular proteins) ( Figure 5B ). We estimated the yield of chLiHsp83-SAG1 expressed in tobacco chloroplast according to the number and weight of mature and old leaves per plant (2.8 g of FW/leaf). A total of 3.6 mg of chLiHsp83-SAG1 could be produced per plant, the great majority of this coming from mature and old leaves.
Antigenicity and immunogenicity analysis of the chLiHsp83-SAG1
In order to evaluate the antigenic functionality of the chLiHsp83-SAG1, the reactivity of human serum samples against SAG1 was analyzed by Western blot under reducing conditions. A total of six human serum samples (3 positive and 3 negative sera)
were tested. A band around 130-kDa (chLiHsp83-SAG1 protein) was detected by the positive serum samples. In addition, these positive sera reacted with other band around 100-kDa. This lower band was also detected by the rabbit anti-SAG1 antibody that was used as positive control ( Figure 6A ). Immunoblot analysis using samples extracted from wild-type plants and EcLiHsp83 protein did not show reactivity with any of the positive serum samples ( Figure 6B and C) .
In order to study the immunogenicity of the chloroplast-made LiHsp83-SAG1, we included an oral immunization protocol using C57BL/6 (H-2b) mice. Lyophilized material was used for oral administration to mice ( Figure S2 ). The amount of chHsp83-SAG1
protein was estimated to be 200 µg/g of lyophilized weight ( Figure S2 ).
Mice were orally immunized with lyophilized LiHsp83-SAG1 leaves (LiHsp83-SAG1 group) or lyophilized wild-type leaves (control group). Mice orally immunized with PBS buffer were also included as an additional control (PBS group). Two weeks after last immunization, mice were challenged with cysts from T. gondii M49 strain [11, 27] . A month later, the number of T. gondii brain cysts was analyzed. The LiHsp83-SAG1 group showed a significant reduction in the cysts (57%) compared to both control and PBS groups ( Figure 7A ). In addition, humoral response was determined by ELISA using rSAG1. Two weeks after the immunization protocol was finished, serum samples were taken from immunized mice. LiHsp83-SAG1 group showed a significant increase of SAG1-specific
IgG antibodies compared to control and PBS groups ( Figure 7B ).
Discussion
LiHsp83 protein used as a carrier improve the expression of T. gondii SAG1 antigen in the chloroplast
SAG1 is well conserved at the immunological and amino acid sequence levels making it an attractive antigen for diagnostics and immunoprophylaxis of Toxoplasmosis [42] . For this reason, this protein has been produced using a variety of expression systems [22] [23] [24] [25] [26] [27] . The SAG1 expression using eukaryotic cell systems, such as Pichia pastoris [43, 44] or CHO cells [45] , resulted in an hyper-glycosylation of the protein (N-and Oglycosilation) that affected its immunogenicity [44] . Since Toxoplasma, like other Apicomplexans does not have N-glycosylation, the chloroplast expression would offer the unique chance to express properly folded non-glycosylated SAG1 protein featuring the native amino acid sequence, which is not possible in the other eukaryotic expression systems like P. pastoris or CHO cells. In the present study, we investigated chloroplast transformation technology as a method to improve the SAG1 expression. In addition, SAG1 was fused to L. infantum Hsp83 as a strategy to enhance recombinant protein stability.
SAG1 transplastomic lines exhibited normal growth and morphology. In contrast,
LiHsp83-SAG1 transplastomic lines showed chlorosis and growth retardation. Several publications have previously reported changes in the phenotype of transplastomic plants [9, 46] . Some of these reports suggest that the potential causes of the phenotypes observed include recombinant protein interference in different metabolic processes or/and the effect of transgene over-expression by itself [46] . In our case, other possible explanation for the phenotypic changes observed in LiHsp83-SAG1 transplastomic plants could include potential disruption of chloroplast Hsp90 function. Chloroplast Hsp90 (Hsp90C) plays an important role in chloroplast biogenesis [47, 48] . hsp90C mutant in Arabidopsis, alters responses to red light and delays chloroplast development [47] . More recently, Feng et al. [48] showed that the co-suppression of Hsp90C cause albino phenotypes in seedlings of Arabidopsis down-regulating the expression of genes involved in photosynthesis.
According to these antecedents, it remains to be determined whether chLiHsp83-SAG1 fusion protein is competing with Hsp90C for the binding to co-chaperones or client proteins affecting the normal phenotype of plants.
In previous reports, we determined that it was feasible to produce the T. gondii
SAG1 protein in plants of Nicotiana spp. by means of transient expression via recombinant
A. tumefaciens [26, 27] . We demonstrated that codon sequence optimization showed a negative impact on protein yield, while endoplasmic reticulum (ER) targeting improved the native SAG1 protein expression reaching yields of approximately 1.3 μg per gram of fresh weight (FW) [27] . Here, the relative amount of SAG1 protein accumulated in transplastomic plants was approximately 0.1-0.2 µg per gram of fresh weight (FW). These expression levels of chSAG1 were lower to those obtained by previous studies that utilized vacuum agroinfiltration method for SAG1 expression in tobacco leaves [26, 27] . Laguía
Becher et al. [27] reported that ER localization allow the accumulation of SAG1 (~1.3 μg per gram of FW) to levels higher than that achieved by chloroplast transformation. The higher levels of expression yield achieved in these studies may be attributable to ER that provides a relatively protective environment with molecular chaperones and stabilizing agents. Similar to studies examining exogenous expression of SAG1 in plants, Bellucci et al. [49] demonstrated that the plant storage protein zeolin also exhibits reduced accumulation when expressed from the chloroplast genome compared to the targeting of the recombinant protein to the ER. Bellucci et al. [49] suggested that higher levels of proteolytic activity present within the chloroplast may account for the reduced zeolin stability compared to the ER accumulation. According to this report we hypothesize that, for some specific proteins, targeting to ER provides a better protective and stabilizing environment than expression in the chloroplast, resulting in increased SAG1 stability and an enhanced level of SAG1 accumulation.
The yields of many proteins that have shown to be difficult to produce in chloroplasts have also been shown to accumulate at higher concentrations when fused to carrier proteins [8, 35, 41, 50] . These findings suggest that the carrier protein would act to stabilize the recombinant protein expressed in chloroplasts and may also protect against proteolysis. Here, we expressed LiHsp83 to function as a carrier for SAG1 antigen in order to improve its expression in transplastomic plants. Fusion of SAG1 to LiHsp83 significantly increased the level of SAG1 accumulation in tobacco chloroplasts (by up to 500-fold). In addition, chLiHsp83-SAG1 protein accumulation does not decrease significantly as the plant ages, although the peak yield would appear to be at 75 days after transplantation, and also highlights a greater stability than the non-fusion SAG1. Also samples of LiHsp83-SAG1 transplastomic plants showed a decrease in the intensity of the band corresponding to the large subunit of pro-homeostatic RuBisCo enzyme with respect to the wild-type tobacco plants at each 50, 75 and 100 days after transplantation. This is consistent with findings from Bally et al. [51, 52] , who demonstrated that the overexpression of recombinant proteins in chloroplasts commonly resulted in reduced expression of endogenous proteins including RuBisCo. However, in our case it remains to be elucidated whether the reduction of RuBisCo observed in LiHsp83-SAG1 transplastomic plants is due to direct interference of the recombinant protein, as it was already mentioned above.
The relative amount of chLiHsp83-SAG1 fusion protein accumulated in transplastomic plants was up to approximately 100 µg per gram of FW (2.5 % of total protein), the majority of which was observed in the soluble protein fraction. These results
show that fusion of SAG1 to LiHsp83 significantly increased the level of chSAG1 accumulation in tobacco chloroplasts. Since chSAG1 and chLiHsp83-SAG1 are synthesized from the same expression cassette, we infer that the low levels of chSAG1 expression are not due to inefficient transgene transcription or translation. In addition, accumulation of the chLiHsp83-SAG1 recombinant fusion protein was found to be higher in plant tissues (mature and old leaves) with higher levels of proteolytic activity. Given that HSP90s are highly stable in different stress conditions, in addition to the functions of HSP90s in promoting correct protein conformation [53, 54] , our results suggest that the fusion of SAG1 to the molecular chaperone LiHsp83 promotes SAG1 stabilization and/or protects it from degradation. Similarly, using tobacco plant chloroplasts, Sanz-Barrio et al. [55, 56] found improved expression and solubility of recombinant human serum albumin (HSA) when fused or co-expressed with thioredoxin f, a plastidic oxidoreductase with chaperone-like properties. Together, these findings support the use of molecular chaperones as carriers to improve the expression yield and solubility of recombinant proteins in chloroplasts.
LiHsp83-SAG1 fusion protein retain the immunogenic and antigenic properties of
T. gondii SAG1 antigen
In order to determine if an antigenic SAG1 version is expressed in LiHsp83-SAG1 transplastomic plants, the reactivity of human serum samples against SAG1 was analyzed by Western blot assays. Our results showed that chLiHsp83-SAG1 was recognized by IgG antibodies in human serum samples from Toxoplasma-infected individuals, indicating that SAG1 fused to LiHsp83 can be recognized by antibodies under reducing condition.
Although conformational epitopes were found in SAG1 protein [24, 57] , the appreciable immunoreactivity of chLiHsp83-SAG1 observed in Western blots against positive sera, suggests that electrophoresis of proteins under reducing conditions makes the antigen react even if chLiHsp83-SAG1 is denatured. Recently, Velmurugan et al. [58] showed that recombinant non-folded SAG1 protein reacted with positive sera from goat, rabbit and humans by Western blot analysis. More recently, Cardona et al. [59] showed that, in humans, anti-SAG1 antibodies recognize lineal epitopes and they are directed mostly against peptides from the SAG1 carboxy-terminus. Additionally, Siachoque et al. [60] observed that the humoral response is specifically directed against these carboxy-terminus peptides in a murine model. In agree with these authors our results suggest that lineal epitopes of SAG1 would be recognized by IgG antibodies from Toxoplasma-infected humans.
Finally, we evaluated the immunogenicity of LiHsp83-SAG1 expressed in chloroplasts. We previously showed that oral immunization with SAG1-expressing leaves did not elicit evident humoral immune responses and protection [27] . A heterologous protocol based on oral immunization with plant-derived SAG1 protein prior to rSAG1 intradermal boost was necessary to elicit significant protection [27] . Here, the oral immunization with chLiHsp83-SAG1 elicited an important reduction of the cyst burden (~57% when compared to control) that correlated with an increased humoral response. Our results suggest that chLiHsp83-SAG1 retain the structural integrity to elicit immunological responses in mice. Although it remains to prove the efficacy of LiHsp83 as oral adjuvant in the antigen presentation, a potential for the use of LiHsp83 as an adjuvant for vaccine antigens has been largely previously based on its immunomodulatory properties [32, 36] . In addition to this feature of LiHsp83, we demonstrate in the current study that LiHsp83 also enhances the solubility and expression of the SAG1 protein during antigen production.
Conclusion
We thus identify further applications of LiHsp83 properties that together with its immunomodulatory attributes, suggest LiHsp83 to be a promising candidate to function as a carrier protein for the expression of vaccine antigens in plants.
We conclude that the fusion of recombinant proteins of interest to LiHsp83 is a novel strategy that presents advantages over other carrier proteins used in heterologous plant expression systems promoting the use of chloroplast transformation technology in molecular farming. 
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